In the eighteenth National Conference on clinical oncology, Professor Liao Ning and other experts in the field to accept the official CSCO m
In the eighteenth National Conference on clinical oncology, Professor Liao Ning and other experts in the field to accept the official CSCO media interview, the hot spot on the day of the meeting.
The CSCO meeting mTOR targeted therapy forum, Professor Liao Ning to solve the problem of endocrine therapy for breast cancer drug resistance, the keynote speech "the best time" mTOR inhibitors in clinical application, the best time to use mTOR inhibitors in patients with breast cancer.
In addition, Professor Liao Ning respectively in breast cancer and other special education respectively on different topics of Thematic Interpretation, "anti HER2 dual targeting neoadjuvant treatment success and failure, gain and loss" and "HER2 positive small tumor auxiliary treatment optimization of speech, and in the transformation of OOTR oncology studied on the special status of Chinese HER2 positive breast cancer patients the special report and discuss with experts research progress.
The current CSCO conference was held for the first time in the SSO-CSCO (American Society of cancer surgery, Chinese Society for surgical oncology). Guangdong General Hospital professor Liao Ning and President of the American Association for cancer surgery (SSO) Charles professor M. Balch served as chairman of the general assembly. In the international concert, the chairman of the breast cancer surgery, University of Arkansas of breast oncology director Professor SuzanneKlimberg V. America "Breast ConservationTreatment Options for Early Stage Breast Cancer" speech; current American cancer surgery magazine editor, former chairman of the American Association of surgical oncology, the American Cancer Society ASCO chief executive officer Charles M. Balch director Professor and Department of breast cancer center of Guangdong General Hospital professor Liao Ning was entitled "Total Mastectomywith Options for Breast speech Reconstructive Surgery" and "Nipple-SparingMastectomy: An oncological safe operation", has received wide attention of scholars at home and abroad.
In the SSO-CSCO (American Society of Surgical Oncology - Chinese tumor surgery association) breast cancer surgical treatment session, Professor Liao Ning proposed to retain full mastectomy nipple surgery is safe; in the case of strictly grasp the indications, there are quite a number of breast cancer patients can choose the surgical treatment.